Home › Malattia di Crohn › California › Los Angeles
Studi clinici su Malattia di Crohn a Los Angeles, CA
15 studi su Malattia di Crohn cercano partecipanti presso sedi a Los Angeles e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
In reclutamentoFase 3
- Cedars Sinai Medical Center ( Site 5080), Los Angeles
- UCLA Clinical & Translational Research Center (CTRC) ( Site 5116), Los Angeles
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- Cedars Sinai Medical Center, Los Angeles
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 2/3
- TLC Clinical Research Inc, Los Angeles
- GastroIntestinal Bioscience, Los Angeles
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
In reclutamentoFase 3
- TLC Clinical Research Inc.-Site Number: 8400030, Los Angeles
- GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019, Los Angeles
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
In reclutamentoFase 2
- Biopharma Informatic, LLC, Los Angeles
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
In reclutamentoFase 2
- Biopharma Informatic, LLC, Los Angeles
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
In reclutamentoFase 4
- Cedars-Sinai Medical Center, Los Angeles
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
In reclutamentoFase 3
- Cedars Sinai Medical Center, Los Angeles
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
In reclutamento
- Cedars-Sinai, Los Angeles
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
In reclutamentoFase 3
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
In reclutamentoFase 4
- Cedars-Sinai, Los Angeles
Precise Infliximab Exposure and Pharmacodynamic Control
In reclutamentoFase 2/3
- Children's Hospital of Los Angeles, Los Angeles
Impact of Prebiotics in Ulcerative Colitis
In reclutamento
- UCLA, Los Angeles
Stem Cell Transplantation in Crohn's Disease
In reclutamentoFase 1/2
- Cedars-Sinai Medical Center, Los Angeles
Studi su Malattia di Crohn in altre città
- New York City, NY35 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Tyler, TX17 studi
- Orlando, FL17 studi
- Houston, TX17 studi
- Atlanta, GA17 studi
- San Antonio, TX15 studi
- San Diego, CA15 studi
- Colorado Springs, CO13 studi
Altri studi a Los Angeles
- Cancro del polmone non a piccole cellule87 studi
- Cancro (tutti i tipi)74 studi
- Cancro al seno73 studi
- Cancro alla prostata61 studi
- Cancro colorettale59 studi
- Cancro metastatico57 studi
- Cancro ovarico50 studi
- Cancro ai polmoni45 studi
- Carcinoma a cellule squamose della testa e del collo42 studi
- Cancro pancreatico35 studi
- Cancro dell'endometrio34 studi
- Melanoma34 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.